Small/medium drug companies experiencing duplicate difficulties.

Published: 2005-06-13 06:55:00

Updated: 2005-06-13 06:55:00

Small and medium sized pharmaceutical companies have faced with duplicated difficulties with the competition against the upper leading rivals and the discriminated assessment system by the GMP.

The small and medium sized pharmaceutical industry said that they should compete local and foreign ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK